Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taras Lyubchenko

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Thescientificworldjournal|November 25, 2010
Ca²+ signaling in B cellsTaras Lyubchenko
Plos One|July 25, 2014
B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritisTaras Lyubchenko, Gary O Zerbe
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 28, 2021
Why are immune adverse events so common with checkpoint inhibitor therapy?Taras Lyubchenko, Donald Y M Leung, Elena Goleva
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathwayTaras Lyubchenko, Joe dal Porto, John C Cambier, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 8, 2020
Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skinTaras Lyubchenko, Hannah K Collins, Elena Goleva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Cutting edge: Complement (C3d)-linked antigens break B cell anergyTaras Lyubchenko, Joseph M Dal Porto, V Michael Holers, et al.
Journal of Leukocyte Biology|November 26, 2008
Role of initial protein phosphorylation events and localized release-activated calcium influx in B cell antigen receptor signalingTaras Lyubchenko, J Paul Nielsen, Sara M Miller, et al.
The Journal of Investigative Dermatology|January 23, 2021
SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca<sup>2+</sup> Mobilization in Primary Human KeratinocytesTaras Lyubchenko, Hannah K Collins, Kathryn A Vang, et al.
Molecular Immunology|July 4, 2012
Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusionClaudia R Amura, Brandon Renner, Taras Lyubchenko, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 15, 2021
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapyElena Goleva, Taras Lyubchenko, Lukas Kraehenbuehl, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Thescientificworldjournal|November 25, 2010
Ca²+ signaling in B cellsTaras Lyubchenko
Plos One|July 25, 2014
B cell receptor signaling-based index as a biomarker for the loss of peripheral immune tolerance in autoreactive B cells in rheumatoid arthritisTaras Lyubchenko, Gary O Zerbe
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 28, 2021
Why are immune adverse events so common with checkpoint inhibitor therapy?Taras Lyubchenko, Donald Y M Leung, Elena Goleva
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathwayTaras Lyubchenko, Joe dal Porto, John C Cambier, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 8, 2020
Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skinTaras Lyubchenko, Hannah K Collins, Elena Goleva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Cutting edge: Complement (C3d)-linked antigens break B cell anergyTaras Lyubchenko, Joseph M Dal Porto, V Michael Holers, et al.
Journal of Leukocyte Biology|November 26, 2008
Role of initial protein phosphorylation events and localized release-activated calcium influx in B cell antigen receptor signalingTaras Lyubchenko, J Paul Nielsen, Sara M Miller, et al.
The Journal of Investigative Dermatology|January 23, 2021
SMOC1 and IL-4 and IL-13 Cytokines Interfere with Ca<sup>2+</sup> Mobilization in Primary Human KeratinocytesTaras Lyubchenko, Hannah K Collins, Kathryn A Vang, et al.
Molecular Immunology|July 4, 2012
Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusionClaudia R Amura, Brandon Renner, Taras Lyubchenko, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 15, 2021
Our current understanding of checkpoint inhibitor therapy in cancer immunotherapyElena Goleva, Taras Lyubchenko, Lukas Kraehenbuehl, et al.
Pageof 3